<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01966081</url>
  </required_header>
  <id_info>
    <org_study_id>Bonithon hors AOI 2008</org_study_id>
    <nct_id>NCT01966081</nct_id>
  </id_info>
  <brief_title>AGARIC Case Control Study</brief_title>
  <acronym>AGARIC</acronym>
  <official_title>Consumption of Fatty Acids, Metabolism of Adipose Tissue and Risk of Colorectal Cancer: AGARIC Case Control Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Centre Hospitalier Universitaire Dijon</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Centre Hospitalier Universitaire Dijon</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The aim of the study is to establish the existence of a relationship between the dietary
      intake of polyunsaturated fatty acids (PUFA) and the risk of colorectal cancer in humans,
      using 2 reliable and complementary biomarkers: the fatty acid-composition of lipids of the
      abdominal subcutaneous adipose tissue and the fatty acid composition of erythrocyte
      phospholipids.
    </textblock>
  </brief_summary>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <primary_completion_date type="Anticipated">November 2014</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Non-Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Measure of polyunsaturated fatty acids in adipose tissue lipids.</measure>
    <time_frame>baselines</time_frame>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">576</enrollment>
  <condition>First Recently-diagnosed Colorectal Cancer</condition>
  <arm_group>
    <arm_group_label>Cases</arm_group_label>
    <arm_group_type>Other</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>controls</arm_group_label>
    <arm_group_type>Other</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Blood sample</intervention_name>
    <arm_group_label>Cases</arm_group_label>
    <arm_group_label>controls</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>tissue samples from abdominal subcutaneous adipose</intervention_name>
    <arm_group_label>Cases</arm_group_label>
    <arm_group_label>controls</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

        CASES

          -  Patients aged ≥ 45 years

          -  with a first recently-diagnosed colorectal cancer

          -  due to undergo elective surgical resection with curative intent (in practice, stage I,
             II, III or IV if there was only one hepatic nodule that was resected with curative
             intent) in one of the 5 following digestive surgery units: CHU de Dijon, CHU de Nancy,
             CHU de Strasbourg, CHU de Reims et CHU and Besançon.

          -  who have given their informed consent

        CONTROLS

          -  Patients aged ≥ 45 years

          -  due to undergo surgery for a benign abdominal disease (sigmoid diverticulitis,
             appendectomy, hiatal hernia …)

          -  matched for abdominal site with cases for age (± 3 years), sex and hospital

          -  Who have given their informed consent

        Exclusion Criteria:

        CASES

          -  pre-operative anticancer treatment (chemo or radiotherapy)

          -  existence of visceral metastases except a single hepatic nodule resected with curative
             intent

          -  familial adenomatous polyposis and HNPCC syndrome (when suspected: inclusion after
             complementary tumor phenotype study: screening for microsatellite instability and/or
             immunohistochemistry study of the expression of DNA mismatch repair proteins.

          -  known inflammatory disease of the intestine (ulcerative colitis, Crohn's disease)

          -  personal history (recent or not) of colorectal cancer

          -  emergency treatment for the presenting complication (perforation, occlusion…)

          -  significant modification in dietary habits during the previous three months

          -  other evolving neoplastic disease

          -  psychic state incompatible with understanding the modalities and the aims of the study
             (notably patients under guardianship)

          -  pregnant or breast-feeding women

        CONTROLS

          -  personal history of cancer or adenomatous colorectal polyps,

          -  emergency intervention

          -  known inflammatory disease of the intestine (ulcerative colitis, Crohn's disease)

          -  personal history (recent or not) of colorectal cancer

          -  emergency treatment for the presenting complication (perforation, occlusion…)

          -  significant modification in dietary habits during the previous three months

          -  evolving neoplastic disease

          -  psychic state incompatible with understanding the modalities and the aims of the study
             (notably patients under guardianship)

          -  pregnant or breast-feeding women
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>45 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
  </eligibility>
  <overall_contact>
    <last_name>Claire BONITHON-KOPP</last_name>
    <phone>3 80 39 33 37</phone>
    <phone_ext>33</phone_ext>
    <email>bonithon@u-bourgogne.fr</email>
  </overall_contact>
  <location>
    <facility>
      <name>CHU Jean Minjoz</name>
      <address>
        <city>Besancon</city>
        <zip>25030</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Georges MANTION</last_name>
      <phone>3 81 66 82 43</phone>
      <phone_ext>33</phone_ext>
    </contact>
  </location>
  <location>
    <facility>
      <name>CHU Dijon</name>
      <address>
        <city>Dijon</city>
        <zip>21079</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Patrick RAT</last_name>
      <phone>3 80 29 37 47</phone>
      <phone_ext>33</phone_ext>
      <email>Patrick.rat@chu-dijon.fr</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Hôpital Robert Debré</name>
      <address>
        <city>Reims</city>
        <zip>51092</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jean-François DELATTRE</last_name>
      <phone>3 26 78 70 79</phone>
      <phone_ext>33</phone_ext>
    </contact>
  </location>
  <location>
    <facility>
      <name>Hôpital Hautepierre</name>
      <address>
        <city>Strasbourg</city>
        <zip>67200</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Serge ROHR</last_name>
      <phone>3 88 12 72 36</phone>
      <phone_ext>33</phone_ext>
    </contact>
  </location>
  <location>
    <facility>
      <name>Hôpital de BRABOIS</name>
      <address>
        <city>Vandoeuvre-les-nancy</city>
        <zip>54511</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Laurent BRESLER</last_name>
      <phone>3 83 15 31 20</phone>
      <phone_ext>33</phone_ext>
    </contact>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>October 2013</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>October 10, 2013</study_first_submitted>
  <study_first_submitted_qc>October 16, 2013</study_first_submitted_qc>
  <study_first_posted type="Estimate">October 21, 2013</study_first_posted>
  <last_update_submitted>October 16, 2013</last_update_submitted>
  <last_update_submitted_qc>October 16, 2013</last_update_submitted_qc>
  <last_update_posted type="Estimate">October 21, 2013</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Colorectal Neoplasms</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

